ACCESSION: MSBNK-SMB_Measured-HSA033P0145007
RECORD_TITLE: Uncharacterized; LC-ESI-QTOF; MS2; NEGATIVE; Averaged data
DATE: 2025.04.02 (Averaged 2025.02.15, Processed 2025.02.15, Annotated 2025.04.01, Curated 2025.04.02)
AUTHORS: Shin-MassBank project
LICENSE: CC BY-NC-SA
PUBLICATION: Liang et al. J Pharm Biomed Anal. 2022, 214, 114718
COMMENT: This is an averaged mass spectra data created by integrating product ion scan data obtained from the follwing DDA dataset.
COMMENT: DATASET_ID MTBLS3854
COMMENT: DATASET_TITLE Long-term low-dose ionizing radiation induced chromosome-aberration-specific metabolic phenotype changes in radiation workers
COMMENT: DATASET_AUTHORS Xinjun Wang
COMMENT: MS1_M/Z_AVERAGED_THRES 20.000
COMMENT: MS2_M/Z_AVERAGED_THRES 20.000
COMMENT: DATASET_FILE_NUM 50
COMMENT: NUM_AVERAGED_SPEC 16
COMMENT: RAW_SPEC {'D136neg_5369': {'bp': 14193.0, 'sum': 28048.0}, 'D170neg_5435': {'bp': 11868.0, 'sum': 23796.0}, 'D108neg_5607': {'bp': 7609.0, 'sum': 16811.0}, 'C14neg_5358': {'bp': 6411.0, 'sum': 13334.0}, 'C4neg_5447': {'bp': 5974.0, 'sum': 11657.0}, 'D64neg_5535': {'bp': 5185.0, 'sum': 11300.0}, 'D65neg_5507': {'bp': 5116.0, 'sum': 11947.0}, 'D170neg_5422': {'bp': 4910.0, 'sum': 11983.0}, 'D143neg_5490': {'bp': 4455.0, 'sum': 9375.0}, 'D74neg_5414': {'bp': 3184.0, 'sum': 8546.0}, 'C6neg_5610': {'bp': 2252.0, 'sum': 6138.0}, 'C7neg_5561': {'bp': 2247.0, 'sum': 5715.0}, 'D145neg_5510': {'bp': 1802.0, 'sum': 4886.0}, 'D207neg_5743': {'bp': 1757.0, 'sum': 4996.0}, 'D121neg_5565': {'bp': 1406.0, 'sum': 3580.0}, 'C4neg_5434': {'bp': 1033.0, 'sum': 3058.0}}
COMMENT: RETENTION_TIME_STDEV 0.005
COMMENT: PRECURSOR_M/Z_RAW 145.062307
COMMENT: PRECURSOR_M/Z_STDEV 0.000573
COMMENT: PRECURSOR_IN_MS1 mz 145.062298; int 85.799; delta(ppm) -0.200573
COMMENT: PROPOSED_CHARGE_STATE -1; mz 146.065333; int 5.087; cor 0.882
COMMENT: PROPOSED_ISOTOPE_STATE ND
COMMENT: PROPOSED_ION_FORM M-H; M-H2O-H; mz 127.051646; int 14.419; cor 0.944
COMMENT: PROPOSED_ION_FORM M-H; M+Na-2H; mz 167.044288; int 42.372; cor 0.856
COMMENT: PROPOSED_MAX_NUM_S 0
COMMENT: PROPOSED_MF SevenGoldenRules 17.512; C4H11N4P; [M-H]1; delta(ppm) -17.512203
COMMENT: PROPOSED_MF SevenGoldenRules 2.951; C5H10N2O3; [M-H]1; delta(ppm) 2.950649
COMMENT: PROPOSED_MF MS-FINDER 3.962; C5H10N2O3; [M-H]-; delta(ppm) 2.972746
COMMENT: PROPOSED_MF SIRIUS5_Sirius 42.106; C5H10N2O3; [M-H]-; delta(ppm) 2.972746
COMMENT: PROPOSED_MF SIRIUS5_Zodiac 1.000; C5H10N2O3; [M-H]-; delta(ppm) 2.972746
COMMENT: PROPOSED_MF SIRIUS6_Sirius 65.054; C5H10N2O3; [M-H]-; delta(ppm) 2.972746
COMMENT: PROPOSED_MF SIRIUS6_Sirius 28.530; C3H8N5O2; [M-H]-; delta(ppm) 12.228659
COMMENT: PROPOSED_MF SIRIUS6_Sirius 1.547; C4H14N2Si2; [M-H]-; delta(ppm) -305943.343848
COMMENT: PROPOSED_MF SIRIUS6_Zodiac 1.000; C5H10N2O3; [M-H]-; delta(ppm) 2.972746
COMMENT: PROPOSED_COMPOUND SIMILARITY:GNPS 4.000; ZDXPYRJPNDTMRX-VKHMYHEASA-N; C5H10N2O3; GLUTAMINE
COMMENT: PROPOSED_COMPOUND SIMILARITY:GNPS 2.000; CXISPYVYMQWFLE-VKHMYHEASA-N; C5H10N2O3; ALA-GLY
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 1.003; CFRMVEKWKKDNAH-VKHMYHEASA-N; [M-H]-; CNC(=O)C[C@H](N)C(O)=O
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 0.933; XOYSDPUJMJWCBH-GSVOUGTGSA-N; [M-H]-; C(C(CC(=O)O)N)C(=O)N
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 0.928; CXISPYVYMQWFLE-UHFFFAOYNA-N; [M-H]-; CC(N)C(=O)NCC(O)=O
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 0.927; YSPAKPPINKSOKX-SGAVLPGINA-N; [M-H]-; CC(=O)NC[C@H](N)C(O)=O
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 0.892; XWBUDPXCXXQEOU-UHFFFAOYSA-N; [M-H]-; O=C(OC)C(N)CC(=O)N
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 7.479; ZDXPYRJPNDTMRX-VKHMYHEASA-N; [M-H]-; L-Glutamine
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 6.841; PHENTZNALBMCQD-UHFFFAOYNA-N; [M-H]-; Ureidoisobutyric acid
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 6.804; CXISPYVYMQWFLE-UHFFFAOYNA-N; [M-H]-; Alanylglycine
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 6.678; VPZXBVLAVMBEQI-VKHMYHEASA-N; [M-H]-; Gly-Ala
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 6.556; YSPAKPPINKSOKX-SGAVLPGINA-N; [M-H]-; UNPD92492
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 6.503; CFRMVEKWKKDNAH-VKHMYHEASA-N; [M-H]-; N(4)-methyl-L-asparagine
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 6.406; QDHYJVJAGQLHBA-UHFFFAOYSA-N; [M-H]-; beta-Ala-Gly
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 6.361; VYAMLSCELQQRAE-UHFFFAOYSA-N; [M-H]-; 2-[(2-aminoacetyl)-methylamino]acetic acid
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 6.349; QYTWIMMLQKHPGL-UHFFFAOYSA-N; [M-H]-; UNPD51326
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 6.325; NRUKNRPYMNPMRU-SEFKMRKONA-N; [M-H]-; UNPD159144
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 6.316; AEFLONBTGZFSGQ-VKHMYHEASA-N; [M-H]-; 4-Amido-4-Carbamoyl-Butyric Acid
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 6.300; HUESNBGSDPNMHU-VFRCHXTQNA-N; [M-H]-; UNPD83830
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 6.136; QDILBYVMDFZEFI-UHFFFAOYSA-N; [M-H]-; 3-[(aminomethyl)-C-hydroxycarbonimidoyl]propanoic acid
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 6.093; XOYSDPUJMJWCBH-GSVOUGTGSA-N; [M-H]-; (3R)-3,5-diamino-5-oxopentanoic acid
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 6.043; ZMGMDXCADSRNCX-IMJSIDKUSA-N; [M-H]-; (5S,6S)-5,6-dihydroxy-1,3-diazepan-2-one
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 6.033; XWBUDPXCXXQEOU-UHFFFAOYSA-N; [M-H]-; methyl 2-amino-3-carbamoylpropanoate
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 6.022; LGJMYGMNWHYGCB-UHFFFAOYNA-N; [M-H]-; 4,5-dihydroxy-1,3-dimethylimidazolidin-2-one
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.847; CJTCFFRJBBMUBJ-UHFFFAOYSA-N; [M-H]-; UNPD71039
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 1.000; ZDXPYRJPNDTMRX-VKHMYHEASA-N; [M-H]-; L-Glutamine
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.975; CFRMVEKWKKDNAH-VKHMYHEASA-N; [M-H]-; N(4)-methyl-L-asparagine
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.971; YSPAKPPINKSOKX-SGAVLPGINA-N; [M-H]-; UNPD92492
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.930; QDHYJVJAGQLHBA-UHFFFAOYSA-N; [M-H]-; beta-Ala-Gly
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.929; CXISPYVYMQWFLE-UHFFFAOYNA-N; [M-H]-; Alanylglycine
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.900; XOYSDPUJMJWCBH-GSVOUGTGSA-N; [M-H]-; (3R)-3,5-diamino-5-oxopentanoic acid
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.891; VPZXBVLAVMBEQI-VKHMYHEASA-N; [M-H]-; Gly-Ala
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.886; QYTWIMMLQKHPGL-UHFFFAOYSA-N; [M-H]-; UNPD51326
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.884; XWBUDPXCXXQEOU-UHFFFAOYSA-N; [M-H]-; methyl 2-amino-3-carbamoylpropanoate
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.863; CJTCFFRJBBMUBJ-UHFFFAOYSA-N; [M-H]-; UNPD71039
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.863; AEFLONBTGZFSGQ-VKHMYHEASA-N; [M-H]-; 4-Amido-4-Carbamoyl-Butyric Acid
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.859; PHENTZNALBMCQD-UHFFFAOYNA-N; [M-H]-; Ureidoisobutyric acid
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.853; VYAMLSCELQQRAE-UHFFFAOYSA-N; [M-H]-; 2-[(2-aminoacetyl)-methylamino]acetic acid
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.831; HUESNBGSDPNMHU-VFRCHXTQNA-N; [M-H]-; UNPD83830
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.826; QDILBYVMDFZEFI-UHFFFAOYSA-N; [M-H]-; 3-[(aminomethyl)-C-hydroxycarbonimidoyl]propanoic acid
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.713; NRUKNRPYMNPMRU-SEFKMRKONA-N; [M-H]-; UNPD159144
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.657; ZMGMDXCADSRNCX-IMJSIDKUSA-N; [M-H]-; (5S,6S)-5,6-dihydroxy-1,3-diazepan-2-one
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.561; LGJMYGMNWHYGCB-UHFFFAOYNA-N; [M-H]-; 4,5-dihydroxy-1,3-dimethylimidazolidin-2-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 3.583; ZDXPYRJPNDTMRX-VKHMYHEASA-N; [M-H]-; (2S)-2,5-diamino-5-oxopentanoic acid
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 2.305; CXISPYVYMQWFLE-VKHMYHEASA-N; [M-H]-; 2-[[(2S)-2-aminopropanoyl]amino]acetic acid
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.611; PHENTZNALBMCQD-UHFFFAOYSA-N; [M-H]-; 3-(carbamoylamino)-2-methylpropanoic acid
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.141; AEFLONBTGZFSGQ-VKHMYHEASA-N; [M-H]-; (4S)-4,5-diamino-5-oxopentanoic acid
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.119; VYAMLSCELQQRAE-UHFFFAOYSA-N; [M-H]-; 2-[(2-aminoacetyl)-methylamino]acetic acid
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.103; CFRMVEKWKKDNAH-VKHMYHEASA-N; [M-H]-; (2S)-2-amino-4-(methylamino)-4-oxobutanoic acid
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.057; QDHYJVJAGQLHBA-UHFFFAOYSA-N; [M-H]-; 2-(3-aminopropanoylamino)acetic acid
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.025; WVJOGYWFVNTSAU-UHFFFAOYSA-N; [M-H]-; 1,3-bis(hydroxymethyl)imidazolidin-2-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.023; YZKPZSDKMUSSHE-UHFFFAOYSA-N; [M-H]-; 2-(carbamoylamino)butanoic acid
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.019; VPZXBVLAVMBEQI-UHFFFAOYSA-N; [M-H]-; 2-[(2-aminoacetyl)amino]propanoic acid
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.014; XWBUDPXCXXQEOU-UHFFFAOYSA-N; [M-H]-; methyl 2,4-diamino-4-oxobutanoate
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.012; QYTWIMMLQKHPGL-UHFFFAOYSA-N; [M-H]-; 4-(carbamoylamino)butanoic acid
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.986; YKPKXMAVLXBQDT-UHFFFAOYSA-N; [M-H]-; ethyl 2-(carbamoylamino)acetate
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.926; ZXUIRBYHSIZRJC-UHFFFAOYSA-N; [M-H]-; 2-(3-aminooxyazetidin-3-yl)acetic acid
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.850; XXNZVJWJWMVONK-UHFFFAOYSA-N; [M-H]-; methyl 2-[(2-aminoacetyl)amino]acetate
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.819; LGJMYGMNWHYGCB-UHFFFAOYSA-N; [M-H]-; 4,5-dihydroxy-1,3-dimethylimidazolidin-2-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.816; SBUPBLSDZSZQBG-UHFFFAOYSA-N; [M-H]-; 1,4-dioxane-2-carbohydrazide
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.813; FMXWPTBQTITILA-UHFFFAOYSA-N; [M-H]-; 2-(carbamoylamino)-2-methylpropanoic acid
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.784; HCPOCMMGKBZWSJ-UHFFFAOYSA-N; [M-H]-; ethyl 3-hydrazinyl-3-oxopropanoate
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.773; WJDYAEIVFPVODA-UHFFFAOYSA-N; [M-H]-; ethyl 3-amino-3-hydroxyiminopropanoate
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.728; SJLBIPLIGYWGJV-UHFFFAOYSA-N; [M-H]-; 4-[methyl(nitroso)amino]butanoic acid
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.573; RUJKVOHTKUJZBV-UHFFFAOYSA-N; [M-H]-; 2-methyl-3-[methyl(nitroso)amino]propanoic acid
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.563; RAUQLNDTFONODT-UHFFFAOYSA-N; [M-H]-; ethyl N-ethyl-N-nitrosocarbamate
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.352; MMAVGZKLTAOVSO-UHFFFAOYSA-N; [M-H]-; [ethyl(nitroso)amino]methyl acetate
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.341; IIGUXNQRQSATOU-UHFFFAOYSA-N; [M-H]-; ethyl 2-[methyl(nitroso)amino]acetate
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -30.841; CXISPYVYMQWFLE; [M-H]-; Alanylglycine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -53.217; QDHYJVJAGQLHBA; [M-H]-; beta-Alanylglycine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -56.600; ZDXPYRJPNDTMRX; [M-H]-; glutamin
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -86.786; YSPAKPPINKSOKX; [M-H]-; nan
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -96.618; CFRMVEKWKKDNAH; [M-H]-; N(4)-methylasparagine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -106.255; VDQFWSAIURVIGH; [M-H]-; N2-acetylserinamide
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -110.349; AEFLONBTGZFSGQ; [M-H]-; |A-glutamine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -112.719; VQVHCAXHYBLRIF; [M-H]-; beta-Methyl-asparagine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -114.588; XOYSDPUJMJWCBH; [M-H]-; 3,5-diamino-5-oxopentanoic acid
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -132.075; YOKCETMQAPIAGM; [M-H]-; Gly-betaAla
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -134.337; VPZXBVLAVMBEQI; [M-H]-; Glcylalanine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -144.043; QYTWIMMLQKHPGL; [M-H]-; 4-ureidobutanoic acid
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -147.870; PHENTZNALBMCQD; [M-H]-; beta-Uba
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -152.491; MXEGHMONPVXZCB; [M-H]-; nan
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -159.274; FMXWPTBQTITILA; [M-H]-; N-Carbamyl-|A-aminoisobutyric acid
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -161.682; VYAMLSCELQQRAE; [M-H]-; Gly-Sarcosin
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -165.360; YKPKXMAVLXBQDT; [M-H]-; Ethyl ureidoacetate
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -171.369; QDILBYVMDFZEFI; [M-H]-; N-(Aminomethyl)succinamic acid
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -172.972; XWBUDPXCXXQEOU; [M-H]-; methyl asparaginate
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -176.040; JNBAANABXDTZJY; [M-H]-; nan
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -188.649; OPVPFHGQNVWIEH; [M-H]-; N~5~-Hydroxy-L-Ornithine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -190.079; PSXXKGJXVFZKFB; [M-H]-; methyl-carbamoyl-D-alanine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -225.480; WVJOGYWFVNTSAU; [M-H]-; Zeset S
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -232.340; CJTCFFRJBBMUBJ; [M-H]-; propyl N-carbamoylcarbamate
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -235.439; HCPOCMMGKBZWSJ; [M-H]-; ACMC-20akzl
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -239.646; OSABMSLCGCTLLC; [M-H]-; 4,5-dimethoxyimidazolidin-2-one
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -251.373; SJLBIPLIGYWGJV; [M-H]-; Nitrosomethyl-3-carboxypropylamine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -256.832; LGJMYGMNWHYGCB; [M-H]-; 4,3-dimethyl-2-imidazalidinone
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -256.985; RAUQLNDTFONODT; [M-H]-; Ethylnitrosourethan
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -278.762; NRUKNRPYMNPMRU; [M-H]-; 3-pyridazinecarboxylic acid,hexahydro-5-hydroxy-
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -280.893; JVRYDNOVFYKHND; [M-H]-; (3R,4R,5R)-3-(hydroxymethyl)-3,4,5,6-tetrahydropyridazine-4,5-diol
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -289.671; WJDYAEIVFPVODA; [M-H]-; ethyl 3-amino-3-hydroxyiminopropanoate
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -291.703; IIGUXNQRQSATOU; [M-H]-; Sarcosine, ethyl ester
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -351.385; MMAVGZKLTAOVSO; [M-H]-; Acetoxymethylethylnitrosamine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -354.684; HUESNBGSDPNMHU; [M-H]-; nan
COMMENT: PROPOSED_COMPOUND SIRIUS5_Confidence:biodatabase 0.295; CXISPYVYMQWFLE; [M-H]-; Alanylglycine
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -33.233; CXISPYVYMQWFLE; [M-H]-; 2-(2-aminopropanamido)acetic acid
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -61.893; ZDXPYRJPNDTMRX; [M-H]-; Hgln
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -96.693; QDHYJVJAGQLHBA; [M-H]-; 2-(3-Aminopropanoylamino)acetate
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -100.305; YSPAKPPINKSOKX; [M-H]-; 2-amino-3-acetamidopropanoic acid
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -119.189; XOYSDPUJMJWCBH; [M-H]-; (3S)-3,5-Diamino-5-oxopentanoic acid
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -124.771; OPVPFHGQNVWIEH; [M-H]-; (2S,5E)-2-amino-5-hydroxyiminopentanoic acid
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -136.850; AEFLONBTGZFSGQ; [M-H]-; 4,5-Diamino-5-oxopentanoic acid
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -138.848; VPZXBVLAVMBEQI; [M-H]-; N-(Glycyl)Alanine
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -155.393; CFRMVEKWKKDNAH; [M-H]-; (R)-2-amino-4-(methylamino)-4-oxobutanoic acid
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -155.730; JNBAANABXDTZJY; [M-H]-; (2S)-4-amino-2-(aminomethyl)-4-oxobutanoic acid
COMMENT: PROPOSED_COMPOUND SIRIUS6_Confidence:biodatabase 0.617; CXISPYVYMQWFLE; [M-H]-; 2-(2-aminopropanamido)acetic acid
COMMENT: CONFIDENCE Level 4: Unequivocal precursor ion formula C5H9N2O3; Top hit by both SIRIUS6_Zodiac and MS-FINDER; and SevenGoldenRules(2), SIRIUS5_Sirius(1), SIRIUS5_Zodiac(1);
CH$NAME: Uncharacterized
CH$COMPOUND_CLASS: Uncharacterized
CH$FORMULA: C39H42O2
CH$EXACT_MASS: 542.318480
CH$SMILES: CCCC#Cc1cc(C#CCCC)cc(C#Cc2cc(C#CC(C)(C)C)c(cc2C#CC(C)(C)C)C2OCCO2)c1
CH$IUPAC: InChI=1S/C39H42O2/c1-9-11-13-15-30-25-31(16-14-12-10-2)27-32(26-30)17-18-33-28-35(20-22-39(6,7)8)36(37-40-23-24-41-37)29-34(33)19-21-38(3,4)5/h25-29,37H,9-12,23-24H2,1-8H3
CH$LINK: PUBCHEM CID:11353257
SP$SCIENTIFIC_NAME: Homo sapiens
SP$LINK: NCBI-TAXONOMY 9606 
SP$SAMPLE: Plasma
AC$INSTRUMENT: Agilent 1290 liquid chromatography system, Agilent Technologies - TripleTOF 6600+ mass spectrometer, AB SCIEX
AC$INSTRUMENT_TYPE: LC-ESI-QTOF
AC$MASS_SPECTROMETRY: MS_TYPE MS2
AC$MASS_SPECTROMETRY: ION_MODE NEGATIVE
AC$MASS_SPECTROMETRY: COLLISION_ENERGY 30 eV
AC$MASS_SPECTROMETRY: FRAGMENTATION_MODE CID
AC$MASS_SPECTROMETRY: ION_SPRAY_VOLTAGE -4.0 kV
AC$MASS_SPECTROMETRY: IONIZATION ESI
AC$MASS_SPECTROMETRY: MASS_ACCURACY MS1(ppm) 20.00; MS2(ppm) 20.00
AC$CHROMATOGRAPHY: COLUMN_NAME ACQUITY UPLC BEH C18 column (1.7 µm, 2.1 mm x 100 mm; Waters)
AC$CHROMATOGRAPHY: FLOW_GRADIENT B conc(%). 0 min: 95, 0.5 min: 95, 7.0 min: 65, 8.0 min: 40, 9.0 min: 40, 9.1 min: 95, 12.0 min: 95.
AC$CHROMATOGRAPHY: FLOW_RATE 0.5 mL/min
AC$CHROMATOGRAPHY: RETENTION_TIME 6.045
MS$FOCUSED_ION: PRECURSOR_M/Z 145.062297
MS$DATA_PROCESSING: RECALIBRATE Data dependent recalibration using whole DDA dataset
PK$SPLASH: splash10-0006-9000000000-d49187f73891a229c984
PK$ANNOTATION: m/z int m/z_nocal m/z_std(ppm) int_std cor n annotation
  41.0046011 30.5141 41.004594 9.4867 12.63 0.8188 12 f{C2H1O1}/32.02ppm,p-C3H8N2O2
  41.9996869 999.0000 41.999683 5.5239 0.00 0.9373 15 f{C1N1O1}/27.37ppm,p-C4H9N1O2
  56.9967068 346.7825 56.996689 7.7197 126.81 0.6720 16 f{C2H1O2}/-26.25ppm,p-C3H8N2O1
  58.0308469 111.3142 58.030827 6.8929 24.51 0.9361 15 f{C2H4N1O1}/17.40ppm,p-C3H5N1O2
  60.9941363 224.3017 60.994112 9.1156 97.05 0.6183 15 f{C1H1O3}/16.70ppm,p-C4H8N2
  61.0188767 44.1264 61.018852 10.1772 41.41 -0.5804 13 f{C1H3N1O2}/31.95ppm,p-C4H6N1O1
  74.0253041 99.6252 74.025255 7.6731 27.26 1.0000 15 f{C2H4N1O2}/7.46ppm,p-C3H5N1O1
  82.0307865 50.1831 82.030736 7.4484 18.24 0.7945 13 f{C4H4N1O1}/11.57ppm,p-C1H5N1O2
  84.0462732 112.4710 84.046223 6.7701 46.69 0.8446 14 f{C4H6N1O1}/9.35ppm,p-C1H3N1O2
  86.0259316 25.2615 86.025881 9.7296 9.26 0.6396 14 f{C3H4N1O2}/13.71ppm,p-C2H5N1O1
  127.0524598 67.3785 127.052425 6.9499 22.84 0.9216 14 f{C5H7N2O2}/9.12ppm,p-H2O1
PK$NUM_PEAK: 11
PK$PEAK: m/z int. rel.int.
  41.004601 30.51 30
  41.999687 999.00 999
  56.996707 346.78 346
  58.030847 111.31 111
  60.994136 224.30 224
  61.018877 44.13 44
  74.025304 99.63 99
  82.030787 50.18 50
  84.046273 112.47 112
  86.025932 25.26 25
  127.052460 67.38 67
//
